Risk factors associated with Hepatitis C among female substance users enrolled in community-based HIV prevention studies

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Nurutdinova, Diana ^a,b   Abdallah, Arbi B ^b   Bradford, Susan ^b   O'Leary, Catina C ^b   Cottler, Linda B ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79953851825     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-126     Document Type: Article

References (49)

1. The burden of hepatitis C in the United States. WR Kim, Hepatology 2002 36 30 S34 10.1002/hep.1840360705 12407574
2. The prevalence of Hepatitis C virus infection in the United States 1999 through 2002. GL Armstrong A Wasley EP Simard GM McQuillan WL Kuhnert MJ Alter, Ann Int Med 2006 144 705 714 16702586 (Pubitemid 46780630)
3. Hepatitis C and liver transplantation. M Berenguer FX Lopez-Labrador TL Wright, J Hepatol 2001 35 666 678 10.1016/S0168-8278(01)00179-9 11690716 (Pubitemid 33078280)
4. Isolation of A Cdna Clone Derived from A Blood-Borne Non-A, Non-B Viral-Hepatitis Genome. QL Choo G Kuo AJ Weiner LR Overby DW Bradley M Houghton, Science 1989 244 359 362 10.1126/science.2523562 2523562 (Pubitemid 19117877)
5. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999 6 35 47 10.1046/j.1365-2893.1999. 6120139.x 10847128
6. Viral hepatitis in minority America. RA Rawls KJ Vega, J Clin Gastroenterol 2005 39 144 151 15681912 (Pubitemid 40130029)
7. Hepatitis C infection in African Americans: its natural history and histological progression. TE Wiley J Brown J Chen, Am J Gastroenterol 2006 97 700 706 10.1111/j.1572-0241.2002.05555.x
8. Hepatitis C in African Americans: Summary of a Workshop. C Howell L Jeffers SJ Hoofnagle, Gastroenterology 2000 119 1385 1396 10.1053/gast.2000. 19582 11054398
9. Viral Hepatitis Consensus Panel 2003. Promoting prevention of viral hepatitis in the African American community. R Hood V Berthaud DA Brooks, et al. J Natl Med Assoc 2003 95 49S 56S 12749609
10. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. MJ Alter D Kruszon-Moran OV Nainan, et al. N Engl J Med 1999 341 556 562 10.1056/NEJM199908193410802 10451460 (Pubitemid 29384163)
11. Epidemiology and natural history of hepatitis C virus infection in injection drug users: Implications for treatment. MS Sulkowski DL Thomas, Clin Inf Dis 2005 40 263 S269 10.1086/427440 (Pubitemid 40490210)
12. Differential seroprevalences of hepatitis C virus, hepatitis B virus and human immunodeficiency virus among intravenous drug users, commercial sex workers and patients with sexually transmitted diseases in Chiang Mai, Thailand. K Taketa S Ikeda N Suganuma, et al. Hepatol Res 2003 27 6 12 10.1016/S1386-6346(03)00163-3 12957200 (Pubitemid 37168645)
13. Sexual activity as a risk factor for hepatitis C. NA Terrault, Hepatology 2002 36 99 S105 10.1002/hep.1840360713 12407582
14. Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner city women. JG Feldman H Minkoff S Landesman J Dehovitz, Sex Transm Dis 2000 27 6 338 342 10.1097/00007435-200007000-00007 10907909 (Pubitemid 30439548)
15. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. DM Gibb RL Goodall DT Dunn, et al. Lancet 2000 356 904 907 10.1016/S0140-6736(00)02681-7 11036896
16. Sharing of drug preparation equipment as a risk factor for hepatitis C. H Hagan H Thiede NS Weiss SG Hopkins JS Duchin ER Alexander, Am J Public Health 2001 91 42 46 10.2105/AJPH.91.9.1350 11189822 (Pubitemid 32049265)
17. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. CJ Howe CM Fuller DC Ompad, et al. Drug Alcohol Depend 2005 79 389 395 10.1016/j. drugalcdep.2005.03.004 16102381 (Pubitemid 41127168)
18. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. C Conry-Cantilena M VanRaden J Gibble, et al. N Engl J Med 1996 334 1691 1696 10.1056/NEJM199606273342602 8637513 (Pubitemid 26193620)
19. Hepatitis C virus infection among noninjecting drug users in New York City. BA Koblin SH Factor YF Wu D Vlahov, J Med Virol 2003 70 387 390 10.1002/jmv.10407 12767001 (Pubitemid 36638051)
20. Hepatitis C among noninjecting drug users: A report. S Tortu A Neaigus J McMahon D Hagen, Subst Use Misuse 2001 36 523 534 10.1081/JA-100102640 11346280 (Pubitemid 32411076)
21. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. S Tortu JM McMahon ER Pouget R Hamid, Subst Use Misuse 2004 39 211 224 10.1081/JA-120028488 15061559 (Pubitemid 38365497)
22. Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user. JM McMahon M Simm D Milano M Clatts, Ann Clin Microbiol Antimicrob 2004 3 6 10.1186/1476-0711-3-6 15132748
23. Reaching and enrolling drug users for HIV prevention: a multi-site analysis. RM Cunningham-Williams LB Cottler WM Compton, et al. Drug Alcohol Depend 1999 54 1 10 10.1016/S0376-8716(98)00149-5 10101612 (Pubitemid 29073373)
24. Are we reaching and enrolling at-risk drug users for prevention studies? RM Cunningham LB Cottler WM Compton, J Drug Issues 1996 26 541 560 (Pubitemid 26338024)
25. Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. LB Cottler WM Compton A Ben Abdallah M Horne D Claverie, Drug Alcohol Depend 1996 41 209 217 10.1016/0376-8716(96)01254-9 8842633 (Pubitemid 26252463)
26. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. MJ Bohn RG Babor H Kranzler, J Studies Alcohol 1995 56 423 432
27. The Diagnostic Interview Schedule. LN Robins LB Cottler KK Bucholz WM Compton, 1996 Version 4.0 (DIS 4.0)
28. Reliability of Self-Reported HIV Risk Behaviors of Drug-Users. R Needle DG Fisher N Weatherby, et al. Psychol Addict Behav 1995 9 242 250 10.1037/0893-164X.9.4.242 (Pubitemid 26019560)
29. Validity of Self-Reported Drug-Use Among Injection-Drug Users and Crack Cocaine Users Recruited Through Street Outreach. NL Weatherby R Needle H Cesari, et al. Eval Program Plann 1994 17 347 355 10.1016/0149-7189(94)90035-3 (Pubitemid 124011602)
30. The reliability of the CIDI-SAM: a comprehensive substance abuse interview. LB Cottler LN Robins JE Helzer, Br J Addict 1989 84 801 814 10.1111/j.1360-0443.1989.tb03060.x 2758153 (Pubitemid 19182559)
31. Reliability of substance use disorder diagnoses among African-Americans and Caucasians. J Horton W Compton LB Cottler, Drug Alcohol Depend 2000 57 203 209 10.1016/S0376-8716(99)00050-2 10661671 (Pubitemid 29537673)
32. WM Wechsberg BR MacDonald ML Dennis, et al. The standard intervention for reduction in HIV risk behavior: Protocol changes suggested by the continuing HIV/AIDS epidemic Bloomington, IL: Chestnut Health Systems 1997
33. Problem gambling and violence among community-recruited female substance abusers. RM Cunningham-Williams AB Abdallah C Callahan L Cottler, Psychol Addict Behav 2007 2 239 243 10.1037/0893-164X.21.2.239 (Pubitemid 47445184)
34. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. SA Villano D Vlahov KE Nelson CM Lyles S Cohn DL Thomas, J Clin Microbiol 1997 35 3274 3277 9399533 (Pubitemid 27505758)
35. Hepatitis C incidence - a comparison between injection and noninjection drug users in New York City. CM Fuller DC Ompad S Galea Y Wu B Koblin D Vlahov, J Urban Health 2004 81 20 24 15047780 (Pubitemid 38622996)
36. Risk Correlates of Prevalent HIV, Hepatitis B Virus, and Hepatitis C Virus Infections Among Noninjecting Heroin Users. VA Gyarmathy A Neaigus M Miller SR Friedman DC Des Jarlais, J Acquir Immune Defic Syndr Hum Retrovirol 2002 30 448 456 (Pubitemid 34857320)
37. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users. A Neaigus VA Gyarmathy M Zhao M Miller SR Friedman DC Des Jarlais, J Infect Dis 2007 195 1052 1061 10.1086/512081 17330797 (Pubitemid 46452112)
38. Tattooing and risk for transfusion-transmitted diseases: the role of the type, number and design of the tattoos, and the conditions in which they were performed. A Nishioka Sde TW Gyorkos L Joseph JP Collet JD Maclean, Epidemiol Infect 2002 128 63 71 11895092 (Pubitemid 34211205)
39. The tattooing paradox: are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection? RW Haley RP Fischer, Arch Intern Med 2003 163 1095 1098 10.1001/archinte.163.9.1095 12742809 (Pubitemid 36548939)
40. Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission. RC Hershow LA Kalish B Sha M Till M Cohen, Sex Transm Dis 1998 25 527 532 10.1097/00007435-199811000-00006 9858348 (Pubitemid 28553608)
41. Non-injection drug use and Hepatitis C Virus: A systematic review. R Scheinmann H Hagan C Lelutiu-Weinberger, et al. Drug and Alcohol Dependence 2007 89 1 12 10.1016/j.drugalcdep.2006.11.014 17174481 (Pubitemid 46602869)
42. Risk factors for hepatitis C virus infection among homeless adults. AM Nyamathi EL Dixon W Robbins, et al. J Gen Intern Med 2002 17 134 143 10.1046/j.1525-1497.2002.10415.x 11841529 (Pubitemid 34595462)
43. Intranasal transmission of hepatitis C virus: virological and clinical evidence. S Aaron JM McMahon D Milano, et al. Clin Infect Dis 2008 47 931 934 10.1086/591699 18764772
44. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). EL Murphy SM Bryzman SA Glynn, et al. Hepatology 2000 31 756 762 10.1002/hep.510310329 10706569 (Pubitemid 30118647)
45. Intranasal cocaine use does not appear to be an independent risk factor for HCV infection. B Galperim H Cheinquer A Stein A Fonesca V Lunge N Ikuta, Addiction 2004 99 973 977 10.1111/j.1360-0443.2004.00761.x 15265094 (Pubitemid 39452809)
46. Hepatitis C and substance use in a sample of homeless people in New York City. A Rosenblum L Nuttbrock HL McQuistion S Magura H Joseph, J Addict Dis 2001 20 15 25 10.1300/J069v20n04-03 11760923 (Pubitemid 33095746)
47. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. RW Haley RPL Fischer, Medicine 2001 80 134 151 10.1097/00005792-200103000-00006 11307589 (Pubitemid 32285210)
48. Risk factors for hepatitis C on the Texas-Mexico border. WL Hand Y Vasquez, Am J Gastroenterol 2005 10 2180 2185 10.1111/j.1572-0241.2005.00238.x
49. Hepatitis C: a sexually transmitted disease? JB Gross, Am J Gastroenterol 2001 96 3051 3053 10.1111/j.1572-0241.2001.05252.x 11721748 (Pubitemid 33095340)